R. Varin

1.5k total citations
67 papers, 1.1k citations indexed

About

R. Varin is a scholar working on Geriatrics and Gerontology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Varin has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Geriatrics and Gerontology, 13 papers in Hematology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Varin's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Pharmaceutical studies and practices (6 papers). R. Varin is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Pharmaceutical studies and practices (6 papers). R. Varin collaborates with scholars based in France, China and Germany. R. Varin's co-authors include Vincent Richard, Christian Thuillez, Fabienne Tamion, Claudine Soria, Paul Mulder, Guy Lerebours, Jean‐Paul Henry, Françoise Lallemand, Jeannette Soria and Massoud Mirshahi and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

R. Varin

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Varin France 18 333 252 155 144 135 67 1.1k
Natale Vazzana Italy 19 549 1.6× 218 0.9× 136 0.9× 130 0.9× 160 1.2× 31 1.5k
Benedetta Porro Italy 20 267 0.8× 311 1.2× 88 0.6× 75 0.5× 155 1.1× 52 1.2k
Steven J.R. Meex Netherlands 24 655 2.0× 271 1.1× 129 0.8× 54 0.4× 115 0.9× 69 1.6k
Hamim Zahir United States 17 423 1.3× 219 0.9× 113 0.7× 181 1.3× 83 0.6× 52 1.3k
Marta Brambilla Italy 24 362 1.1× 424 1.7× 122 0.8× 99 0.7× 111 0.8× 78 1.8k
Mojca Stegnar Slovenia 20 284 0.9× 226 0.9× 166 1.1× 67 0.5× 86 0.6× 75 1.3k
Kenneth A. Schwartz United States 22 505 1.5× 230 0.9× 103 0.7× 88 0.6× 231 1.7× 58 1.5k
Garry McDowell United Kingdom 24 957 2.9× 348 1.4× 122 0.8× 130 0.9× 102 0.8× 71 1.8k
Jeanenne J. Nelson United States 19 650 2.0× 381 1.5× 138 0.9× 102 0.7× 61 0.5× 42 1.5k
T D Bjornsson United States 16 333 1.0× 159 0.6× 187 1.2× 80 0.6× 67 0.5× 23 979

Countries citing papers authored by R. Varin

Since Specialization
Citations

This map shows the geographic impact of R. Varin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Varin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Varin more than expected).

Fields of papers citing papers by R. Varin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Varin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Varin. The network helps show where R. Varin may publish in the future.

Co-authorship network of co-authors of R. Varin

This figure shows the co-authorship network connecting the top 25 collaborators of R. Varin. A scholar is included among the top collaborators of R. Varin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Varin. R. Varin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varin, R., et al.. (2025). Osmolality of compounded oral liquids for pediatrics. European Journal of Pediatrics. 184(4). 252–252.
2.
Vittecoq, Olivier, et al.. (2024). Impact of the Clinical Pharmacist in Rheumatology Practice: A Systematic Review. Healthcare. 12(15). 1463–1463. 2 indexed citations
3.
4.
5.
6.
7.
Daouphars, Mikaël, et al.. (2021). Évaluation d’une salle de naissance des erreurs virtuelle en formation initiale. Sages-Femmes. 20(2). 47–52. 1 indexed citations
8.
Imbert, Laurent, et al.. (2021). Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review. Journal of Personalized Medicine. 11(1). 37–37. 66 indexed citations
9.
Goudemand, Jenny, et al.. (2021). Costs and management of patients with hemophilia A in France: the Hemraude study. The European Journal of Health Economics. 23(1). 23–32. 6 indexed citations
10.
Lamoureux, Fabien, et al.. (2021). Stability study of a compounded oral solution of nicardipine for the treatment of hypertension in children. European Journal of Pharmaceutical Sciences. 160. 105738–105738. 7 indexed citations
11.
Gillibert, André, et al.. (2021). Clinical impact of a personalized pharmaceutical plan on opioid management in non-cancer pain: a pilot study. Clinical Rheumatology. 40(11). 4659–4663. 2 indexed citations
12.
Lequerré, Thierry, et al.. (2020). The impact of an in-department pharmacist on the prevention of drug iatrogenesis in a rheumatology department. Clinical Rheumatology. 40(1). 359–368. 3 indexed citations
13.
Leguelinel-Blache, Géraldine, Christel Castelli, Clarisse Roux‐Marson, et al.. (2018). Impact of collaborative pharmaceutical care on in-patients’ medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study). Trials. 19(1). 19–19. 13 indexed citations
14.
Hu, Chaoquan, Mélanie Di Benedetto, R. Varin, et al.. (2014). Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells. Oncology Letters. 9(3). 1287–1292. 9 indexed citations
15.
H, Lu, Jean‐Pierre Vannier, Limin Huang, et al.. (2014). Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib. OncoTargets and Therapy. 7. 2249–2249. 17 indexed citations
16.
Fang, Yantian, Christine Patte‐Mensah, Ayikoe Guy Mensah‐Nyagan, et al.. (2013). The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cells. International Journal of Oncology. 44(2). 539–547. 19 indexed citations
17.
Varin, R., Pezhman Mirshahi, Christophe Klein, et al.. (2013). Whole blood clots are more resistant to lysis than plasma clots - greater efficacy of rivaroxaban. Thrombosis Research. 131(3). e100–e109. 73 indexed citations
18.
Daouphars, Mikaël, et al.. (2012). Knowledge Assessment and Information Needs of Oncology Nurses Regarding Inpatient Medication. Clinical journal of oncology nursing. 16(2). 182–187. 7 indexed citations
19.
Savoye, Guillaume, Fabienne Tamion, Vincent Richard, R. Varin, & Christian Thuillez. (2005). HEMORRHAGIC SHOCK RESUSCITATION AFFECTS EARLY AND SELECTIVE MESENTERIC ARTERY ENDOTHELIAL FUNCTION THROUGH A FREE RADICAL-DEPENDENT MECHANISM. Shock. 23(5). 411–416. 19 indexed citations
20.
Richard, Vincent, et al.. (2002). α2‐adrenoceptor ligands inhibit α1‐adrenoceptor‐mediated contraction of isolated rat arteries. Fundamental and Clinical Pharmacology. 16(4). 281–287. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natale Vazzana Breakdown of academic impact, for papers by Benedetta Porro Breakdown of academic impact, for papers by Steven J.R. Meex Breakdown of academic impact, for papers by Hamim Zahir Breakdown of academic impact, for papers by Marta Brambilla Breakdown of academic impact, for papers by Mojca Stegnar Breakdown of academic impact, for papers by Kenneth A. Schwartz Breakdown of academic impact, for papers by Garry McDowell Breakdown of academic impact, for papers by Jeanenne J. Nelson Breakdown of academic impact, for papers by T D Bjornsson
Rankless by CCL
2026